“…The first members of what is now a rather large family of natural products were described more than 50 years ago, and new ones continue to be reported on a regular basis. , The extraordinary range of biological properties displayed by the RALs, which include (among other things) antimalarial, antiviral, antifungal, nematocidal, and antiparasitic activities, has attracted significant attention although probably not as much as the capacities of some of them to act as potent and highly selective inhibitors of kinases and the chaperone heat shock protein 90 (Hsp90). , As such, certain RALs have come to be regarded as important leads for the development of new oncolytic agents. Certainly, an impressive range of derivatization and analoguing programs , has been launched on this basis and such efforts have even led to a number of clinical trials …”